openPR Logo
Press release

Immunoassay Instruments Market Share, Growth and Key Players Analysis Beckman Coulter, Ortho Clinical Diagnostics, bioMérieux, Abbott Laboratories, Sysmex Corporation, DiaSorin

12-13-2018 02:04 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Immunoassay Instruments Market Share, Growth and Key Players

The global immunoassay instruments market is expected to witness considerable growth during the forecast period, mainly due to the rising prevalence of chronic and infectious diseases around the globe. Immunoassay is a laboratory based diagnostic procedure, that is performed using an immunological reaction of antibodies. The formation of antibody antigen complexes in blood samples and other body fluids, are measured by immunoassay instruments and are usually engaged to detect analytes in quantitative or qualitative manner.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market/report-sample

ELISA, radioimmunoassay, rapid tests, PCR, western blot, and ELISPOT are the major technologies on which the immunoassay instruments are based. The study reveals that among these technologies, ELISA held the largest share in the immunoassay instruments market in 2017, due to the wide adoption of this testing technique for detecting chronic and infectious diseases. ELISA is further sub-categorized into 1st generation, 2nd generation, 3rd generation, and 4th generation ELISA tests.

North America held the largest share in the global immunoassay instruments market in 2017, due to the expanding biotechnology and pharmaceutical industries, rising prevalence of chronic diseases, technological advancements, and adoption of automated platforms for immunoassay testing in the region. Furthermore, the region is pronounced with the presence of major players, which also supports the growth of the market demand.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=immunoassay-instruments-market

However, increasing support by the government of developing economies, such as India, and China, is expected to drive the pace of the Asia-Pacific (APAC) immunoassay instruments market in the coming years. For instance, indo-U.S. bilateral collaborative research grants on human immune phenotyping and infectious disease, an indo-U.S. vaccine action program, provides funding opportunity for researchers to conduct a collaborative research on human immunophenotyping studies. Such initiatives are expected to promote the growth of the APAC market during the forecast period.

Factors driving the immunoassay instruments market include discovery of specific biomarkers, extensive use of immunoassays in oncology, rising geriatric population, and the growing preference for personalized medicine. Increasing research activities focused on exploring the potential application of immunoassay tests in identifying infectious diseases, toxicology testing and other drug monitoring tests are some other factors that are expected to drive the market growth in the coming years. Furthermore, the key market players are continuously involved in the development of compact, reliable and portable products, as a result of technological advancements, which is also supporting the market demand.

Browse report at: https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market

Some of the key players in the immunoassay instruments market are Beckman Coulter, Inc., F. Hoffman-La Roche, Ltd., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoassay Instruments Market Share, Growth and Key Players Analysis Beckman Coulter, Ortho Clinical Diagnostics, bioMérieux, Abbott Laboratories, Sysmex Corporation, DiaSorin here

News-ID: 1438715 • Views:

More Releases from P&S Intelligence

Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls
North America, the Largest Revenue Producer in Public Safety and Security Market
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities

All 5 Releases


More Releases for Immunoassay

Insights On Immunoassay Market Outlook - Ken Research
An immunoassay is a biochemical analysis that measures the existence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays in scientific research are typically used in the study of biological systems by tracing different proteins, hormones, and antibodies. In industry, they are used to identify contaminants in food and water, and to monitor specific molecules used during
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC
Bahrain Immunoassay Analyzer Market: Ken Research
The report titled "Bahrain Blood Gas and POC Immunoassay AnalyzerMarket Outlook to 2026-Multiple programs to modernize the Bahraini healthcare sector in future including Health Insurance, Health centers and Primary Care Autonomy" provides a comprehensive analysis of the Diagnostic Equipments used in Hospitals and Independent Labs. Report also covers overview and genesis of the industry, product wise market size in terms of installed base; market segmentation by type of device, type
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027". The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027. Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market? Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.
Immunoassay Growth Insights 2019 by Major Key Drivers like biotechnology and pha …
Immunoassay Market Highlights Immunoassay is widely used in significant areas of pharmaceutical analysis which include diagnosis of diseases and in therapeutic drug monitoring. A number of factors such as the increasing prevalence of chronic conditions, growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, rising use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and